Alkermes (ALKS) Net Income (2010 - 2026)
Alkermes (ALKS) recorded Net Income of $524,000 in Q2 2026, down 99.4% from $87.1 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' Net Income came in at $66.1 million as of Jun 30, 2026, down 81.0% year-over-year; for FY2025, it came in at $241.66 million, down 34.2% from FY2024.
- Across earlier years, Net Income came in at $367.07 million in FY2024 (+3.2%), $355.76 million in FY2023, -$158.27 million in FY2022 and -$48.17 million in FY2021.
- Quarterly Net Income has ranged from -$66.53 million in Q1 2026 to $237.07 million in Q2 2023 over the past five years.
- On a year-over-year basis, Net Income rose in two of the last seven quarters, with an average decline of 13.8%.
- Peak year-over-year performance for Net Income in the last five years was growth of 93.4% in Q3 2024, against a decline of 99.4% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -$66.53 million (Q1 2026), $49.34 million (Q4 2025) and $82.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524,000.00 |
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.34 Mn |
| Sep 30, 2025 | 82.76 Mn |
| Jun 30, 2025 | 87.10 Mn |
| Mar 31, 2025 | 22.46 Mn |
| Dec 31, 2024 | 146.50 Mn |
| Sep 30, 2024 | 92.38 Mn |
| Jun 30, 2024 | 91.36 Mn |
| Mar 31, 2024 | 36.83 Mn |
| Dec 31, 2023 | 112.78 Mn |
| Sep 30, 2023 | 47.76 Mn |
| Jun 30, 2023 | 237.07 Mn |
| Mar 31, 2023 | -41.85 Mn |
| Dec 31, 2022 | 96.86 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 125.44 Mn |
| Sep 30, 2021 | -28.99 Mn |
API Access
Alkermes Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();